期刊文献+

诱导型环氧合酶-2在CD40配体诱导基质金属蛋白酶表达中的作用 被引量:1

rhCD40L induces expression of matrix metalloproteinases in cultured U937 cells by cyclooxygenase-2 pathway
下载PDF
导出
摘要 目的:探讨重组人CD40配体(rhCD40L)诱导U937细胞中基质金属蛋白酶(MMPs)表达的作用及其与诱导型环氧合酶-2(COX-2)途径的关系。方法:体外培养U937细胞,以不同浓度(0.1、0.2、0.4 mg/L)的rhCD40L和不同浓度(10-5 mol/L、10-4 mol/L、10-3 mol/L)的COX-2特异性抑制剂(NS-398)分别刺激24 h。在加入终浓度为0.4 mg/L rhCD40L的基础上,加入终浓度为10-4 mol/L的NS-398,共同刺激U937细胞24 h后,收集培养上清液,用酶谱法测定MMPs的活性。结果:rhCD40L可使MMP-2和MMP-9的活性明显增加(P<0.01),且呈剂量依赖性;NS-398可抑制MMP-2和MMP-9的活性,且抑制作用随剂量的增加而增强(P<0.05)。结论:rhCD40L以浓度依赖的方式诱导MMPs表达,rhCD40L对MMPs的诱导作用可能与COX-2途径有关。 AIM: To evaluate matrix metalloproteinase(MMP) expression induced by rhCD40L in cultured U937 cell and possible effects of cyclooxygenase-2(COX-2).METHODS: U937 cells were treated with rhCD40L and NS-398 in different concentrations,respectively,and on the basis of the treatment with rhCD40L,U937 cells were cocultured with NS-398 and aspirin.The supernatant of the U937 cells cultures was collected.Zymography was performed by SDS-PAGE in 10% gels containing 0.1%(w/v) gelatin(denatured collagen) at 4℃.The activities of MMPs were detected by the grey level of the band.RESULTS: rhCD40L increased the activity of MMPs in a dose-dependent manner,whereas NS-398 significantly inhibited the activity of MMPs.NS-398 significantly inhibited the activity of MMPs induced by rhCD40L.CONCLUSION: rhCD40L can induce U937 cells to secrete MMPs in a dose-dependent manner,which may be related to COX-2 pathway.
出处 《心脏杂志》 CAS 2011年第1期56-58,64,共4页 Chinese Heart Journal
基金 上海市卫生局科研课题资助(2007105)
关键词 CD40配体 诱导型环氧合酶-2 基质金属蛋白酶 单核细胞系U937 CD40 ligand; cyclooxygenase-2; matrix metalloproteinases; monocyte;
  • 相关文献

参考文献10

  • 1Schonbeck U, Libby P. CD40 signaling and plaque instability[J]. Circ Res, 2001, 89(12):1092-1103.
  • 2Nagashima H, Aoka Y, Sakomura Y, et al. Matrix metalloproteinase 2 is suppressed by trapidil, a CD40-CD40 ligand pathway inhibitor, in human abdominal aortic aneurysm wall[J]. J Vasc Surg, 2004, 39(2):447-453.
  • 3Smola-Hess S, Schnitzler R, Hadaschik D, et al. CD40L induces matrix-metalloproteinase-9 but not tissue inhibitor of metalloproteinases-1 in cervical carcinoma cells: imbalance between NF-kappaB and STAT3 activation[J]. Exp Cell Res, 2001, 267(2):205-215.
  • 4Santovito D, Mezzetti A, Cipollone F. Cyclooxygenase and prostaglandin synthases: roles in plaque stability and instability in humans[J]. Curr Opin Lipidol, 2009, 20(5):402-408.
  • 5Bujold K, Rhainds D, Jossart C, et al. CD36-mediated cholesterol efflux is associated with PPARgamma activation via a MAPK-dependent COX-2 pathway in macrophages[J]. Cardiovasc Res, 2009, 83(3):457-464.
  • 6Rival Y, Puech L, Taillandier T, et al. PPAR activators and COX inhibitors selectively block cytokine-induced COX-2 expression and activity in human aortic smooth muscle cells[J]. Eur J Pharmacol, 2009, 606(1-3):121-129.
  • 7Rupp J, Berger M, Reiling N, et al. Cox-2 inhibition abrogates Chlamydia pneumoniae-induced PGE2 and MMP-1 expression[J]. Biochem Biophys Res Commun, 2004, 320(3):738-744.
  • 8Choi YA, Lee DJ, Lim HK, et al. Interleukin-1beta stimulates matrix metalloproteinase-2 expression via a prostaglandin E2-dependent mechanism in human chondrocytes[J]. Exp Mol Med, 2004, 36(3):226-232.
  • 9Cipollone F, Fazia M, Iezzi A, et al. Blockade of the angiotensin II type 1 receptor stabilizes atherosclerotic plaques in humans by inhibiting prostaglandin E2-dependent matrix metalloproteinase activity[J]. Circulation, 2004, 109(12):1482-1488.
  • 10Pillinger MH, Rosenthal PB, Tolani SN, et al. Cyclooxygenase-2-derived E prostaglandins down-regulate matrix metalloproteinase-1 expression in fibroblast-like synoviocytes via inhibition of extracellular signal-regulated kinase activation[J]. J Immunol, 2003, 171(11):6080-6089.

同被引文献4

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部